The U.S. Food and Drug Administration on Monday approved Pfizer's respiratory syncytial virus (RSV) vaccine for use in women during the middle of the third trimester of pregnancy to protect their babies.
respiratory syncytial virus vaccine for use in women during the middle of the third trimester of pregnancy to protect their babies.
A Pfizer spokesperson could not comment on the FDA's reasoning for the more limited window for administering the vaccine, but said the company was confident the shot would have a positive impact on public health and RSV rates. Infants are at greatest risk for severe illness from RSV. An estimated 58,000 to 80,000 children below the age of five years are hospitalized every year due to RSV infection in the U.S., according to government data.
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA approves 1st maternal RSV vaccine to help protect infantsThe U.S. Food and Drug Administration has approved the first maternal vaccine intended to help protect newborns against respiratory syncytial virus (RSV).
Read more »
Flu, Covid and RSV: Preventing another 'Tripledemic'As summer nears its end and the school year begins, it's a good time to think about getting those fall vaccinations against viruses that circulate in colder weather. A so-called 'Tripledemic' of Covid-19, the flu and RSV spread throughout the country last winter. To prevent a repeat, health officials are encouraging everyone to get vaccinated against Covid-19 and the flu, and now there are new protections against RSV. CBS News Bay Area's Ryan Yamamoto asks Dr. Jorge Salinas, infectious diseases specialist at Stanford Health Care, about the recommended vaccines
Read more »
Neurocrine Biosciences price target raised at Oppenheimer after FDA approves movement disorder treatmentNeurocrine Biosciences Inc. said Friday that the U.S. Food and Drug Administration has approved Ingrezza for treatment of an involuntary movement disorder...
Read more »
Regeneron shares climb after FDA approval of macular degeneration treatmentShares of Regeneron Pharmaceuticals Inc. gained 1.4% premarket on Monday after the company said late Friday that the U.S. Food and Drug Administration had...
Read more »
On Abortion Pills, Federal Appeals Court Prescribes Justice for FDAAmericans concerned about the safety, health, and welfare of women and girls in this country received welcome news last week.
Read more »